Public vaccine manufacturing capacity in the Latin American and Caribbean region: Current status and perspectives
- 26 October 2011
- journal article
- review article
- Published by Elsevier in Biologicals
- Vol. 40 (1) , 3-14
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Global, regional, and national causes of child mortality in 2008: a systematic analysisThe Lancet, 2010
- The role of emerging manufacturers in access to innovative vaccines of public health importanceVaccine, 2010
- The Brazilian vaccine manufacturers' perspective and its current statusBiologicals, 2009
- Emerging markets & emerging needs: Developing countries vaccine manufacturers' perspective & its current statusBiologicals, 2009
- Reaching international GMP standards for vaccine production: challenges for developing countriesExpert Review of Vaccines, 2009
- Innovative vaccine production technologies: The evolution and value of vaccine production technologiesArchives of Pharmacal Research, 2009
- Challenges and potential solutions to innovative vaccine development for developing countriesProcedia in Vaccinology, 2009
- Access to vaccine technologies in developing countries: Brazil and IndiaVaccine, 2007
- Human vaccine research and development: An overviewVaccine, 2005